alexa The Exclusions From Patentability And Especially The Rationale For Medical Use Patents
ISSN: 1948-593X

Journal of Bioanalysis & Biomedicine
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Share This Page

Additional Info

Loading Please wait..

3rd International Conference and Exhibition on Biowaivers, Biologics & Biosimilars
October 27-29, 2014 Hyderabad International Convention Centre, Hyderabad, India

Dieter Tzschoppe
ScientificTracks Abstracts: J Bioanal Biomed
DOI: 10.4172/1948-593X.S1.013
The presentations address the procedural and patentability aspects of the grant and opposition procedure at the European Patent Office for applications and patents relating to pharmaceuticals and biotechnology. Exceptions to patentability relating to methods of treatment of the human or animal body by therapy or surgery and diagnostic methods are discussed. The patentability of pharmaceuticals ranging from new compounds defined by markush type formulas, polymorphs, salts, drug formulations, combinations of active agents and medical uses is presented. The patentability discussion also comprises the criteria for novelty assessment and the problem-solution approach for inventive step as used by the EPO.
Dieter Tzschoppe studied chemistry at the University of Stuttgart (Germany) and holds a PhD in Organic Chemistry from the University of Besancon (France). He joined the EPO in 1985 in The Hague (Netherlands) as Search Examiner in the field of pharmaceutical formulations. After his transfer to Munich (Germany) in 1989 he worked as search and substantive examiner in the field of medical use inventions. Since 1999 he is Director of units of about 30 examiners, first in organic chemistry, since 2005 in pharmacology and since 2013 additionally in galenics in the cluster Pure and Applied Organic Chemistry (PAOC). Responsible for external relations for cluster PAOC, he frequently represents the cluster/EPO as speaker in conferences or in the framework of international cooperation.
image PDF   |   image HTML
Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version